Minimal residual disease (MRD) analysis in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)] by real time PCR (RT-PCR) and flow cytometry (FC).

被引：0

作者：

Perea, G

Lasa, A

Aventin, A

Domingo, A

Villamor, N

de Llano, MPQ

Llorente, A

Junca, J

Palacios, C

Fernandez, C

Gilallart, M

Font, L

Tormo, M

Florensa, L

Bargay, J

Marti, JM

Vivancos, P

Torres, P

Berlanga, J

Brunet, S

Sierra, J

Nomdedeu, JF

机构：

[1] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[2] Bellvitge Hosp, Hosp Llobregat, Barcelona, Spain

[3] Hosp Clin Barcelona, Barcelona, Spain

[4] Hosp Virgen Victoria, Malaga, Spain

[5] Hosp Joan 23, Tarragona, Spain

[6] Hosp Germans Trias & Pujol, Badalona, Spain

[7] Hosp Gen Valle Hebron, Barcelona, Spain

[8] Hosp Josep Trueta, Girona, Spain

[9] Hosp Arnau Vilanova, Lerida, Spain

[10] Hosp Verge Cinta, Tarragona, Spain

[11] Hosp Clin, Valencia, Spain

[12] Hosp Mer, Barcelona, Spain

[13] Hosp Son Llatzer, Mallorca, Spain

[14] Mutua Terrassa, Barcelona, Spain

[15] Clin Teknon, Barcelona, Spain

[16] Hosp Juan Canalejo, La Coruna, Spain

来源：

BLOOD | 2004年 / 104卷 / 11期

关键词：

D O I：

10.1182/blood.V104.11.2989.2989

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2989

引用

页码：817A / 817A

页数：1

共 50 条

[21] Quantification of CBFβ/MYH11 transcripts in inv(16) acute myeloid leukemia (AML) by real time RT-PCR.
Marcucci, G
Caligiuri, MA
Maghraby, EA
Archer, KJ
Döhner, K
Schlenk, RF
Döhner, H
Bloomfield, CD
BLOOD, 1999, 94 (10) : 625A - 625A
[22] Comparison of immunocytochemistry, real-time quantitative RT-PCR and flow cytometry for detection of minimal residual disease in neuroblastoma
Ifversen, MRS
Kågedal, B
Christensen, LD
Rechnitzer, C
Petersen, BL
Heilmann, C
INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 27 (01) : 121 - 129
[23] Predicting outcome based on minimal residual disease (MRD) using multiparameter flow cytometry (FC) in acute myeloid leukemia (AML) patients (Pts)
Sardesai, Sagar D.
Tan, Wei
Ford, Laurie Ann
Deeb, George
Block, Anne Marie W.
Sait, Sheila N. J.
McCarthy, Philip L.
Vigil, Carlos E.
Griffiths, Elizabeth A.
Thompson, James E.
Wang, Eunice S.
Wallace, Paul K.
Wetzler, Meir
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[24] Quantification of CBFβ/MYH11 fusion transcript by Real Time RT-PCR in patients with INV(16) acute myeloid leukemia
Marcucci, G
Caligiuri, MA
Döhner, H
Archer, KJ
Schlenk, RF
Döhner, K
Maghraby, EA
Bloomfield, CD
LEUKEMIA, 2001, 15 (07) : 1072 - 1080
[25] Quantification of CBFβ/MYH11 fusion transcript by Real Time RT-PCR in patients with INV(16) acute myeloid leukemia
G Marcucci
MA Caligiuri
H Döhner
KJ Archer
RF Schlenk
K Döhner
EA Maghraby
CD Bloomfield
Leukemia, 2001, 15 : 1072 - 1080
[26] DETECTION OF FUSION TRANSCRIPTS OF T(8 21) BY RT-PCR IN AML PATIENTS COULD BE USED FOR MONITORING MINIMAL RESIDUAL DISEASE
CHEN, J
BALL, ED
BLOOD, 1993, 82 (10) : A127 - A127
[27] Evaluation of quantitative RT-PCR in monitoring minimal residual disease in patients with AML M2 and t(8;21).
Tobal, K
Yin, JAL
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 242 - 242
[28] Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR
Kerst, G
Kreyenberg, H
Roth, C
Well, C
Dietz, K
Coustan-Smith, E
Campana, D
Koscielniak, E
Niemeyer, C
Schlegel, PG
Müller, I
Niethammer, D
Bader, P
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (06) : 774 - 782
[29] AN EFFICIENT AND SIMPLE MULTIPARAMETER FLOW CYTOMETRY PROTOCOL TO DETECT MINIMAL RESIDUAL DISEASE (MRD) FOR ACUTE MYELOID LEUKEMIA (AML)
Li, Ke
Wang, Hui
BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 356 - 357
[30] PCR and RT-PCR based minimal residual disease (MRD) detection in long term follow up childhood acute lymphobalstic leukemia(ALL).
Gameiro, P
Papaioannou, M
Moreira, I
Yetgin, S
Potter, MN
Prentice, HG
Mehta, AB
Hoffbrand, AV
Foroni, L
BLOOD, 2001, 98 (11) : 318A - 318A

← 1 2 3 4 5 →